LOGIN
Erythropoietin reduces the risk of exposure to allogeneic blood transfusion in THA and TKA
February 2017
Erythropoietin reduces the risk of exposure to allogeneic blood transfusion in THA and TKA
Study Type:Therapy
OE Level Evidence:2
Journal Level of Evidence:N/A
Erythropoietin to reduce allogeneic red blood cell transfusion in patients undergoing total hip or knee arthroplasty.
Vox Sang. 2016 Oct;111(3):219-225Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Synopsis
Seven randomized controlled trials were included in this systematic review and meta-analysis to determine the effectiveness of erythropoietin in reducing the risk of exposure to allogenic blood transfusions in patients undergoing total hip and knee arthroplasty procedures. Outcomes assessed were the incidence of allogeneic blood transfusion, units of allogeneic blood transfused, the incidence of a...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Join the Conversation
Please Login or Join to leave comments.